Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients (NCT03036930)
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
This phase II trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejection. This study will help inform our scientific understanding about vaccine-induced immune responses among immunosuppressed individuals.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Age range: 18 Years to 49 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
- Cedars-Sinai Medical Center — Los Angeles, California
- UCSF Medical Center-Mount Zion — San Francisco, California
- Northwestern University — Chicago, Illinois
- Mayo Clinic in Rochester — Rochester, Minnesota
- UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Human Papillomavirus Infection
- Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study — Liberia, Guanacaste Province
- Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care — Buffalo, New York
- Promoting HPV Vaccination Among Young Adults in Texas — Houston, Texas
- Throat and Other HPV-Related Cancers in Men: Identifying Them Early — Houston, Texas
- Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study — Liberia, Guanacaste Province
Explore by condition: All Human Papillomavirus Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.